Codexis (NASDAQ:CDXS) stock climbed 11% in post-market trading after the company announced it had granted an exclusive global license to Roche (OTCQX:RHHBY) for its newly engineered double-stranded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback